Premium
Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium
Author(s) -
Oberley Terry D.,
Zhong Weixiong,
Szweda Luke I.,
Oberley Larry W.
Publication year - 2000
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/1097-0045(20000701)44:2<144::aid-pros7>3.0.co;2-g
Subject(s) - prostate , prostate cancer , epithelium , superoxide dismutase , oxidative stress , antioxidant , pathology , oxidative phosphorylation , medicine , biology , cancer , biochemistry
BACKGROUND The risk for prostate cancer seems to be reduced by certain antioxidant compounds (vitamins E and A, and selenium). METHODS Antioxidant enzymes and oxidative damage products were localized in normal prostatic epithelium and malignant glands in primary and metastatic prostatic adenocarcinomas, using well‐characterized antibodies and immunoperoxidase techniques. RESULTS Antioxidant enzymes and four markers of oxidative damage were compared in basal and secretory cells of normal prostatic epithelium and prostate adenocarcinoma cells, and each cell type had unique patterns of enzymes and oxidative damage products. One marker of oxidative damage, a fluorophore derived from 4‐hydroxy‐2‐nonenal‐lysine adduction, was found in secretory cells of normal but not malignant epithelium, demonstrating a different oxidative metabolism in normal vs. malignant prostate epithelium. Metastatic lesions from primary prostate cancer had higher levels of manganese superoxide dismutase and nuclear oxidative damage products than did primary tumors. CONCLUSIONS Antioxidant enzymes and oxidative damage products are modulated in metastatic compared to primary prostate cancer. Prostate 44:144–155, 2000. © 2000 Wiley‐Liss, Inc.